Treatment of Active Idiopathic Inflammatory Myopathies by Low-Dose Interleukin-2: A Prospective Cohort Pilot Study

INTRODUCTION: Treatment of idiopathic inflammatory myopathies (IIMs) is challenging due to a lack of safe and efficacious medication. Low-dose interleukin-2 (IL-2) treatment emerges as a new option in active IIMs. This study aims to explore the clinical and immunological effects of low-dose IL-2 in...

Descripción completa

Detalles Bibliográficos
Autores principales: Miao, Miao, Li, Yuhui, Huang, Bo, Chen, Jiali, Jin, Yuebo, Shao, Miao, Zhang, Xia, Sun, Xiaolin, He, Jing, Li, Zhanguo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8217480/
https://www.ncbi.nlm.nih.gov/pubmed/33852146
http://dx.doi.org/10.1007/s40744-021-00301-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8217480/
https://www.ncbi.nlm.nih.gov/pubmed/33852146
http://dx.doi.org/10.1007/s40744-021-00301-3

Ejemplares similares